NELL2 promotes motor and sensory neuron differentiation and stimulates mitogenesis in DRG in vivo  by Nelson, Branden R et al.
www.elsevier.com/locate/ydbio
Developmental Biology 270 (2004) 322–335NELL2 promotes motor and sensory neuron differentiation and
stimulates mitogenesis in DRG in vivo
Branden R. Nelson,a,b,1 Karen Claes,b Valerie Todd,b Marta Chaverra,b and Frances Lefcortb,c,*
aDepartment of Chemistry and Biochemistry, Montana State University, Bozeman, MT 59717, USA
bDepartment of Cell Biology and Neuroscience, Montana State University, Bozeman, MT 59717, USA
cWWAMI Medical Education Program, Montana State University, Bozeman, MT 59717, USAReceived for publication 11 October 2003; revised 1 March 2004; accepted 1 March 2004
Available online 16 April 2004Abstract
We previously identified a secreted glycoprotein, neural epidermal growth factor-like like 2 (NELL2), in a subtraction screen designed to
identify molecules regulating sensory neurogenesis and differentiation in the chick dorsal root ganglion (DRG). Characterization of NELL2
expression during embryogenesis revealed that NELL2 was specifically expressed during the peak periods of both sensory and motor neuron
differentiation, and within the neural crest was restricted to the sensory lineage. We now provide evidence for a function for NELL2 during
neuronal development. We report here that NELL2 acts cell autonomously within CNS and PNS progenitors, in vivo, to promote their
differentiation into neurons. Additionally, neuron-secreted NELL2 acts paracrinely to stimulate the mitogenesis of adjacent cells within the
nascent DRG. These studies implicate dual functions for NELL2 in both the cell autonomous differentiation of neural progenitor cells while
simultaneously exerting paracrine proliferative activity.
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Within the developing vertebrate nervous system, an
intricate interplay between extrinsic and intrinsic cellular
signals ultimately regulates the genesis and differentiation
of the neurons that comprise the CNS and PNS. In the
process, a variety of neuronal cell types are generated from
a population of mitotically active progenitor cells. The
question of how such diversity is generated has been a major
focus in developmental biology. An experimentally rich
system in which to address this issue is the chick dorsal root
ganglia (DRG), which derive from a subset of migrating
neural crest cells that coalesce laterally to the neural tube
(Horstadius, 1950; Lallier and Bronner-Fraser, 1988; Le
Douarin, 1982; Teillet et al., 1987; Weston, 1970). To0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Washington, Seattle, WA 98195, USA.identify genes that regulate this process, we compared cDNA
from immature embryonic day E4.5 DRG, during the peak
period of neurogenesis and differentiation (Carr and Simp-
son, 1978), to cDNA from mature E8.5 DRG, which are
composed of differentiated postmitotic neurons and glia,
using a subtraction/differential screening strategy (Nelson
et al., 2004). From this subtraction screen, we identified a
candidate cDNA fragment, neural epidermal growth factor-
like (NEL, Matsuhashi et al., 1995), by DNA sequencing and
BLASTanalysis of GenBank (Altschul et al., 1990). Chicken
NEL is approximately 40–50% homologous to mammalian
NEL-like 1 (NELL1), and approximately 80–90% homolo-
gous to mammalian NEL-like 2 (NELL2, Kuroda et al., 1999;
Watanabe et al., 1996). Therefore, we refer to chicken NEL as
NELL2; chicken NELL1 has not yet been identified.
The NELL genes belong to the (1) laminin G/N-termi-
nal thrombospondin-1 (N-TSP1)/Pentraxin supergene fam-
ily, which is involved in cell/cell communication and
contact (Beckmann et al., 1998); (2) chordin-like domain
family; and (3) the epidermal growth factor-like (EGF-like)
domain families. NELL contains a cleavable signal peptide
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chordin-like/von Willebrand Factor C (C/vWc) domains,
and has been proposed to act as a signaling molecule
involved in cell growth and/or differentiation and as a
possible trophic factor (Aihara et al., 2003; Garcia Abreu
et al., 2002; Kuroda et al., 1999; Matsuhashi et al., 1995;
Watanabe et al., 1996). The NELL genes code for large
peptides of approximately 90 kDa and are heavily glyco-
sylated with an additional approximately 50 kDa of N-
linked carbohydrate moieties for total monomeric size of
approximately 140 kDa (Kuroda et al., 1999). The secreted
forms of the NELL peptides are processed to approximate-
ly 130 kDa monomers and form approximately 400 kDa
trimers in solution (Kuroda et al., 1999; see Fig. 1a for
schematic of NELL2).Fig. 1. NELL2 is secreted from in ovo transfected spinal cord. (a) Schematic of
terminal heparin-binding domain (HB) and coiled–coiled (cc) domain; C/vWc, ch
motif, blue are Ca+ 2 binding type; predicted N-linked glycosylation sites denoted w
(9e10, DHSB) demonstrates that NELL2Myc is secreted by transfected COS7 c
putative homotrimer in solution from both cell types: (+) conditions are NELL2-tra
Denaturing SDS-PAGE conditions yield a single band for NELL2 peptide at appro
spinal cord cultures; (f) immunoprecipitation of NELL2Myc with anti-Myc a
Nondenaturing NATIVE-PAGE conditions yields two bands for NELL2, ind
homotrimeric NELL2 in solution. COS7 (d) and spinal cord (h) cultures were imm
and GFP expression from pMES (Swartz et al., 2001b). Scale bar: 12 Am.NELL1 and NELL2 gene expression is tightly regulat-
ed in several vertebrate tissues both during development
and in the adult (Kim et al., 2002; Kuroda et al., 1999;
Luce and Burrows, 1999; Matsuhashi et al., 1995; Nelson
et al., 2002; Oyasu et al., 2000; Watanabe et al., 1996).
NELL2 expression during development is temporally and
spatially restricted to periods of differentiation in discrete
regions of the nervous system, the pharyngeal arches, and
the forelimb and trunk skeletal muscle (Nelson et al.,
2002). In the nervous system, NELL2 expression is
maximal during the peak period of neurogenesis and
differentiation of both spinal cord motor neurons and
sensory neurons within the DRG (Nelson et al., 2002).
Interestingly, in a manner reminiscent of Notch/Delta
interactions, NELL2-positive, postmitotic neurons are of-NELL2 homotrimer: N-TSP1, N-terminal thrombospondin 1 motif with N-
ordin-like/von Willebrand factor c motif; EGF, epidermal growth factor-like
ith hatched lines. Western analysis of supernatants with anti-Myc antibody
ells (b–d) and chick embryonic spinal cord cultures (e–h), and forms the
nsfected; ( ) conditions are empty vector control pmiw transfected. (b, e, f)
ximately 130 kDa from both COS7 cells and in ovo transfected embryonic
ntibody (Clontech) from remaining spinal cord supernatant in E. (c, g)
icating oligomeric complexes, consistent with previous descriptions of
unolabeled with anti-Myc antibody (9e10, red) to confirm dual NELL2Myc
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progenitor cells (Nelson et al., 2002). Although NELL2’s
expression correlates temporally with the differentiation of
both motor and sensory neurons, the functional role of
NELL2 in vivo has not been determined.
To determine its role in vivo, we have used in ovo
plasmid injection and electroporation to analyze the effect
of ectopic NELL2 expression in CNS and PNS progenitor
cells (Muramatsu et al., 1997; Swartz et al., 2001a). We
demonstrate that NELL2 drives CNS progenitor cells in the
spinal cord to exit the cell cycle, promoting their precocious
differentiation in a cell autonomous fashion without altering
cellular identity, and within motor pools, NELL2 increases
the rate of motor neuron differentiation. NELL2 also acts
cell autonomously to bias migrating neural crest cells to
localize within the DRG anlagen, and to differentiate into
sensory neurons rather than peripheral glia, without altering
sensory subtype identity. Furthermore, neuron-secreted
NELL2 acts paracrinely to induce adjacent cells in the
immature DRG to proliferate. These data suggest dual roles
for NELL2 in mediating the differentiation of neuronal
progenitor cells while simultaneously stimulating neighbor-
ing cells to proliferate.Methods
NELL2 subcloning and expression in vitro
A 6 myc epitope tag was subcloned into the C-terminus
of chicken NELL2 by replacing the MscI/AflII fragment in
the parent expression vector pmiwC3 (gift of S. Matsuha-
shi), with a linker designed to remove the stop codon and
insert EcoRV/NsiI restriction sites to allow cloning of a PCR
amplified myc tag containing these sites, pNELL2Myc.
Sequencing verified that the NELL2Myc fusion was in-
frame. Removing NELL2 from the parent vector with
HindIII, followed with re-ligation, created pmiw empty
vector control plasmid.
Expression of rNELL2Myc was verified with transient
transfection of 5 Ag each of pNELL2Myc and pmiw into
35 mm dishes of COS7 cells with Fugene (Roche) as
directed. Supernatants were collected after 48 h, spun, and
prepared for polyacrylamide gel electrophoresis (PAGE)
under denaturing and nondenaturing conditions. For dena-
turing SDS-PAGE analysis, 100 Al of supernatants were
mixed with 50 Al of 2 sample buffer consisting of SDS
and B-mercaptoethanol, and boiled for 5 min to reduce
peptides to their primary structure. For nondenaturing
NATIVE-PAGE, 100 Al of supernatants was mixed with
sample buffer without denaturants and not boiled to
maintain protein quaternary structure. Twenty-five micro-
liters of each denatured and nondenatured NELL2Myc and
control pmiw supernatants were loaded into 6% SDS-
PAGE and 6% NATIVE-PAGE (without SDS) gels, re-
spectively, and ran with SDS and non-SDS running buffersaccordingly. Gels were electrotransferred onto PDVF mem-
branes, which were blocked in 6% BSA, 1% casein at
room temp for 1 h. Membranes were immunoblotted with
the primary anti-myc antibody 9e10 (1:10, DHSB) over-
night at 4jC, washed 4, incubated with secondary goat
anti-mouse, biotinylated 1 h at room temp, and washed
4. Biotinylated complexes were detected with ABC
treatment (Vectastain, Vector) and chemiluminescence
(SuperSignal, Peirce).
NELL2Myc coding sequence was subcloned into pMES
(Swartz et al., 2001b; gift of C. Krull) by sequential digests
with AflII, blunt-ending with T4 DNA polymerase, and then
with XbaI, which was cloned into the XbaI/SmaI sites of
pMES, now called pNELL2. Expression of NELL2Myc
from pNELL2 was confirmed with transient transfections
of COS7 cells, along with control pGFP plasmid, and
analysis of supernatants as described. Dual expression of
NELL2Myc and GFP from pNELL2 in the same cell was
confirmed by briefly fixing these cultures with 4% parafor-
maldehyde at room temperature for 30 min. Dishes were
washed and blocked with 10% serum for 1 h, immunola-
beled with primary 9e10 anti-myc antibody at 1:10 dilution
overnight at 4jC, washed 4, incubated with goat anti-
mouse/Texas Red secondary antibody (Jackson Labs) 1:250
dilution at room temp for 1 h, washed, mounted with
ProLong Antifade (Molecular Probes), and analyzed by
epifluorescence.
Combined in situ hybridization and immunolabeling
Double immunocytochemical detection of BrdU and
neurofilament after NELL2 in situ hybridization of E4.5/
stage 25 embryos was performed as previously described
(Nelson et al., 2002, in press).
In ovo transfections and analysis
In ovo microinjection and electroporation of plasmids
were performed as described (Muramatsu et al., 1997;
Swartz et al., 2000a). All embryos were treated in accor-
dance with IACUC stipulations. Briefly, plasmid prepara-
tions (5 Ag/Al) were injected into the neural tubes of
windowed chicken embryos at HH stage 10 (Hamburger
and Hamilton, 1951), electroporated with gold electrodes
(three pulses, 10–20 V, 50 ms) and a square wave electro-
porater (BTX), resealed, and incubated to desired stages.
Expression of NELL2Myc from in ovo transfected cells
was confirmed by dissecting pNELL2 and control pGFP-
transfected spinal cords incubated to E4.5, dissociating and
culturing overnight in DMEM–10% serum. One hundred
microliters of each supernatant from these cultures were
collected and analyzed under denaturing SDS-PAGE as
described. Additionally, 1 ml of the remaining supernatants
was used for immunoprecipitation experiments by adding
2 Al of the anti-Myc antibody (Clontech), incubating
overnight at 4jC on a rotator, adding 50 Al of equilibrated
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washed 4 with PBS, stripped, and denatured with 25 Al
of SDS sample buffer and boiling for 5 min, followed by
SDS-PAGE analysis as described. Dual expression of
NELL2Myc and GFP in the same cells in spinal cord
cultures was detected as described.
For in vivo analysis, transfected embryos at the desired
stages were examined for GFP expression with a fluores-
cent stereo-dissecting microscope (M2Bio, Zeiss) equipped
with eGFP filter set. Embryos with detectable fluorescence
in forelimb level DRG were collected, their trunks re-
moved and fixed in 4% paraformaldehyde for 4–6 h at
4jC, and cryoprotected through a sucrose gradient before
being embedded in O.C.T. (Tissue-Tek) for cryosectioning.
Transverse cryosections of transfected forelimb level trunk
regions were analyzed to identify the fate of pNELL2 and
control pGFP-transfected cells by immunolabeling with an
array of cell type specific markers: MNR2, Isl1, Pax6,
Pax7, Nkx2.2, Ben (all DHSB monoclonal antibodies, and
all used at 1:20 dilution); rat anti-BrdU used at 1:2000
dilution; rabbit anti-phosphohistone 3 (Upstate Biotechnol-
ogy) used at 1:500, mouse anti-Tuj1 (Chemicon) used at
1:2000 dilution; rabbit anti-TrkA, TrkB, TrkC (Lefcort
et al., 1996; Rifkin et al., 2000) used at 1:2000 dilution.
Secondary antibodies were species-specific Cy3, TRITC,
or Texas Red conjugated used at 1:500 dilution. Sections
were analyzed by epifluorescence for GFP expression and
red-secondary immunolabeling with appropriate filter sets,
photographed as double exposures, scanned into and
compiled with Adobe Photoshop. Embryos were serially
sectioned at 10 Am through the forelimbs and into the
upper trunk region. All GFP+ cells in all sections were
scored for presence or absence of immunolabeling with the
respective antibody markers being assessed. Double-count-
ing cells was easily avoided based on morphological dis-
tinctions between neighboring cells. Each slide contained ca
16 sections, and at least three slides per embryo were
scored for expression of each different antibody marker;
at least three embryos were sectioned and labeled and
scored per marker, except for the trk labeling of E6.5–
E7.5 embryos in which only two embryos per marker were
analyzed. Total number of embryos analyzed for each com-
parison is stated as is the total number of cells scored in
each figure legend. Statistical significance was determined
with Student’s t test.Results
NELL2 is secreted in vivo
Expression of NELL2 was verified by transiently trans-
fecting pNELL2:Myc and empty control parent vector
(pmiw) into COS7 cells and analyzing supernatants and/or
immunoprecipitations from supernatants for secreted
NELL2. We found that like mammalian NELL2 (Kurodaet al., 1999), chicken NELL2 is secreted from COS7 cells
and forms the putative homotrimer in solution (Figs. 1b, c).
For in ovo microinjections/electroporations, NELL2:Myc
was subcloned into the bicistronic eukaryotic expression
vector pMES (Swartz et al., 2001b), which contains the
CMV IE and chick beta-actin promoters and the IRE-
S2:eGFP sequence for dual expression of NELL2:Myc
and eGFP in the same cell, now called pNELL2. Co-
expression of both NELL2 and GFP in vitro was confirmed
in transient COS7 cells transfections (Fig. 1d). Co-expres-
sion in ovo was confirmed by microinjecting and electro-
porating pNELL2 into HH stage 10 chick neural tubes
(Hamburger and Hamilton, 1951), incubating until stage
25, dissecting and culturing dissociated transfected spinal
cords overnight. Supernatants and cultures were analyzed as
described. NELL2 was secreted from in ovo transfected
spinal cord cells and formed the putative homotrimer in
solution (Figs. 1e–g) and was co-expressed with GFP in the
same cells (Fig. 1h).
An intriguing observation from our previous in situ
hybridization analysis was that NELL2 expression in the
developing pharyngeal arch target fields was maximal as its
expression waned in the respective innervating cranial
ganglia (Nelson et al., 2002). Similarly, NELL2 expression
in brachial DRG decreased as its expression became re-
stricted to discrete regions within the target forelimb. This
raised the question whether NELL2 might function as a
target-derived factor that attracted or repelled extending
neurites, similar to other glycoproteins that also contain
EGF-like domains such as ROBO and its ligand Slit
(reviewed in Nguyen-Ba-Charvet and Chedotal, 2002). We
tested this hypothesis by coculturing COS7 cell pellets
expressing rNELL2 next to explanted E4.5 DRG in collagen
gels (Tessier-Lavigne et al., 1988). These studies did not
reveal any overt ability for secreted rNELL2 to attract or
repel extending DRG neurites (data not shown).
Spinal cord progenitor cells expressing NELL2 withdraw
from the cell cycle and translocate to the mantle layer
To determine whether ectopic expression of NELL2
altered the behavior of neural progenitors cells, stage 10
neural tubes were injected with pNELL2 or pGFP control
plasmid and electroporated (Muramatsu et al., 1997;
Swartz et al., 2001a). Transverse sections of stage 18–
20/E3 and stage 25/E4.5 (Figs. 2A, B) control GFP-
transfected embryos demonstrated that many progenitor
cells located next to the lumen in the ventricular zone
continued to express GFP several days after transfection,
as did their progeny. In contrast, CNS progenitors trans-
fected with NELL2 translocated from the ventricular zone
to the mantle layer where differentiation occurs; this
asymmetry in cellular distribution coincided with the
onset of ectopic protein expression (Figs. 2C, D; ectopic
GFP could be observed approximately 6–12 h post-trans-
fection). These data demonstrate that within CNS progen-
Fig. 2. Spinal cord progenitor cells expressing NELL2 withdraw from the cell cycle and translocate to the mantle layer. All transverse sections of in ovo
transfected embryos are oriented with dorsal–ventral as top–bottom and left – right as ventricular surface-mantle layer of the spinal cord, respectively. (A–D)
Transverse sections of stage 18–20 (E3) and stage 25 (E4.5) spinal cord demonstrate that control GFP-transfected progenitor cells (A, B, respectively) in the
mitotic ventricular zone and their progeny in the postmitotic mantle layer express high levels of ectopic GFP; ventricular zone (left) and mantle layer (right)
denoted by hatched lines. In contrast, upon ectopic expression of NELL2, progenitor cells at E3 (C) translocate from the mitotically active ventricular zone to
the mantle layer to differentiate, and by E4.5 (D) have become restricted to the mantle layer. (E–G) Transfected control GFP (E) embryos pulsed with BrdU at
stage 18, sectioned and processed for BrdU immunocytochemistry (red), demonstrate that the majority of GFP-transfected progenitor cells in the ventricular
zone incorporated BrdU; asterisks denote postmitotic cells in the mantle zone. (F) In contrast, NELL2-transfected progenitors still present within the ventricular
zone did not incorporate BrdU (arrowheads; asterisks denote postmitotic cells in the mantle zone). (G) Quantification of effects of ectopic NELL2 expression
on proliferation measured by BrdU immunolabeling; GFP: n = 3 embryos, 90 cells; NELL2: n = 3 embryos; 297 cells; P V 0.0001. (H–J) Similarly,
transfected embryos immunolabeled for H3 (red) demonstrate that control GFP (H) transfected progenitor cells in M phase are immunopositive, while NELL2-
transfected cells are not; arrowheads denote immunopositive transfected cells. (J) Quantification of effects of ectopic NELL2 expression on proliferation
measured by H3 immunolabeling. GFP:68 cells, n = 2 embryos; NELL2:187 cells, n = 2 embryos; P V 0.004. Scale bar: A–C, 25 Am; D, 45 Am; E, F, 25 Am;
H, I, 20 Am.
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or autocrinely via cell–surface interactions.
We next analyzed whether ectopic NELL2 expression
directly forced CNS progenitors to withdraw from the cell
cycle, by combining microinjection/electroporations with
BrdU pulses to label CNS progenitors in S phase. Transfected
embryos incubated to stage 18–19 were pulsed for 3 h to
insure labeling of the majority of mitotically active progenitor
cells within the ventricular zone. These studies revealed that
only aminority of NELL2+ transfected cells in the ventricular
zone were BrdU positive (28.0F 1.5%), in contrast to control
GFP-transfected embryos in which the majority of trans-
fected cells were BrdU+ (74.0 F 3.6%; P V 0.0001; Figs.
2E–G). Similarly, analysis of the subset of mitotically active
progenitor cells in M phase identified with anti-phosphohi-
stone 3 (H3) antibody revealed that a greater percentage of
control transfected cells in the ventricular zone were H3+
(38.0F 3.0%) thanwere NELL2-transfected (11.0F 2.0%;P
V 0.004; Figs. 2H–J). Additional evidence supporting
NELL2-induced cell cycle withdrawal is the fact that we
consistently observed fewer NELL2-transfected cells than
control GFP-transfected cells. A role for NELL2 in neuronal
differentiation is consistent with its normal expression pattern
in the spinal cord where it is robustly expressed by post-
mitotic neurons at E4.5 as they emigrate from the ventricular
zone and settle in themantle zone (Fig. 3). Thus, similar to the
proneural transcription factor NKL that drives progenitor
cells to exit the cell cycle and promotes their differentiation
in the spinal cord (Lamar et al., 2001), ectopic NELL2
expression in CNS progenitors promotes their mitotic arrest
and translocation to the mantle layer cell autonomously.
NELL2 promotes differentiation of spinal cord progenitors
without altering their cellular identity
To determine whether ectopic NELL2 influenced speci-
fication of cellular identities, we immunolabeled sections of
transfected embryos with antibodies that distinguish sub-Fig. 3. NELL2 is expressed by nascent, postmitotic CNS neurons as they leave the
injected with BrdU and incubated for 2–3 h, fixed, sectioned, and hybrid
immunocytochemistry with antibodies to BrdU (B, C) and neurofilament (B, C).
mitotically active ventricular zone, but rather, migrating toward and residing withclasses of cell types within the spinal cord. CNS progenitors
in the developing spinal cord give rise to distinct classes of
cells according to a homeodomain transcription factor code,
generated in response to ventralizing and dorsalizing gra-
dients of secreted sonic hedgehog and BMPs, respectively
(Briscoe et al., 2000; reviewed by Lee and Pfaff, 2001).
Neither transfection of control GFP nor NELL2 induced
ectopic motor neuron formation dorsal or ventral to their
normal domain, as assessed by immunoexpression of the
motor neuron specification factor MNR2 (Fig. 4A). Fur-
thermore, NELL2 transfection did not induce the formation
of ectopic Pax6, Pax7, or Nkx2.2 progenitors outside of
their normal domains within the ventricular zone of the
spinal cord (data not shown).
To further investigate the effect of ectopic-NELL2 ex-
pression in CNS progenitors, we used MNR2 expression
within developing motor neuron pools as a measure of motor
neuron differentiation. MNR2 normally is expressed at high
levels by progenitors as they migrate from the ventricular
zone to the nascent motor neuron domain in the mantle layer
(Novitch et al., 2001; Tanabe et al., 1998). Within developing
motor pools, MNR2 is expressed at higher levels medially
and at lower levels more laterally; as nascent motor neurons
mature in the lateral zone, they increase their expression of
more mature motor neuron markers such as Isl1. Analysis of
transfected motor progenitor cells approximately 36 h fol-
lowing transfection indicated a relative increase in the
number of ectopic-NELL2/MNR2+ immunopositive cells
(74.0 F 8.5%, Figs. 4B, F) compared to GFP/MNR2+ cells
from control transfected embryos (56.0F 3.4%, Fig. 4F), the
result of NELL2’s ability to induce differentiation of pro-
genitor cells and their concomitant translocation from the
ventricular zone. Furthermore, most NELL2+ cells at this
stage were also immunopositive for later motor neuron
markers such as Isl1 (Fig. 4D). However, within the next
24 h, a significantly greater percentage of motor neurons
ectopically expressing NELL2 had reduced their expression
of MNR2 (34.0 F 2.0%, Fig. 4F) compared to control GFP-ventricular zone and coalesce in the mantle zone. A stage 24/25 embryo was
ized with a probe to detect NELL2 mRNA (A, B) then labeled by
Note that by this stage, the vast majority of NELL2+ cells are not in the
in the mantle zone of the spinal cord. Scale bar: 60 Am.
Fig. 4. NELL2 does not alter the identity of transfected CNS progenitor cells, but rather, increases their rate of differentiation. (A–B) NELL2-transfected
embryo, stage (st 18–20/E3) immunolabeled with the motor neuron marker MNR2 (red), demonstrates that forced NELL2 expression in progenitor cells does
not induce ectopic motor neuron formation dorsal (asterisks) or ventral to their normal domain. (B) A higher magnification view of the motor neuron domain
shown in A indicates that many NELL2+ cells are also MNR2+ (arrowheads). (C) However, by stage 25/E4.5, the majority of NELL2-transfected motor
neurons have downregulated expression of MNR2. (D) Many NELL2+ cells at E3 have already differentiated into mature motor neurons and express Isl1
(yellow cells; arrowheads). (E) At stage (25/E4.5), control GFP-transfected motor neuron progenitor cells can still be detected in the medial ventricular zone
(asterisks), and are immunopositive (arrowhead) for MNR2; cells more laterally situated in the motor neuron domain have matured into MNR2-cells (arrow).
(F) Quantification of MNR2 expression in transfected motor neurons. E4.5: GFP, n = 3 embryos; 362 cells; NELL2, n = 3 embryos, 215 cells; P V 0.015.
Scale bar: A, 50 Am; B, C, E, 30 Am; D, 40 Am.
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4E, F). Furthermore, control GFP-transfected progenitor
cells remained in the Olig1/2 domain in the ventricular zone
(Fig. 4E), while NELL2-transfected cells migrated out of this
proliferative zone into the mantle layer to differentiate
(Fig. 4F). Therefore, ectopic NELL2 expression increased
the rate at which motor neuron progenitor cells withdrew
from the cell cycle, translocated to the mantle layer, and
ceased expression of MNR2, indicating that NELL2 promot-
ed their precocious differentiation. Further support for this
finding is that by E4.5, while MNR2 expression is decreasing
in the NELL2-transfected cells, their expression of Islet-1 is
increasing: 85.3 F 3% (n = 3 embryos, 158 cells) of the
NELL2-transfected cells were immunopositive for Islet1.
This also indicates that the vast majority (if not all) of
NELL2-transfected cells differentiated into neurons.
NELL2 biases migrating neural crest cells to localize to the
DRG
Transfection of control GFP plasmid into premigratory
neural crest at stage 10 labeled all neural crest derivatives
(Fig. 5A), in particular, enteric, sympathetic, sensory, and
melanocyte derivatives, as described in previously pub-
lished lineage-tracing experiments (Frank and Sanes,
1991; Fraser and Bronner-Fraser, 1991). In contrast, ectopic
expression of NELL2 biased the migration of the early wave
of neural crest cells such that they preferentially localized in
the DRG anlagen (Fig. 5B). Examination of the primary
chain of sympathetic ganglia at stage 25 revealed that
control GFP-labeled cells contributed to sympathetic gan-
glia, while ectopic NELL2-labeled cells were absent from
sympathetic ganglia (Figs. 5C, D): note that this also
demonstrated the existence of non-NELL2-transfected neu-
ral crest cells that were capable of generating and populating
sympathetic ganglia. Quantification of the position of trans-
fected cells confirmed that ectopic NELL2 expression
biased neural crest cells to localize or commit preferentially
to the sensory (95.0 F 5%) rather than sympathetic ganglia
(Fig. 5E). In control embryos, 65.0 F 3% (P V 0.007) of
transfected cells were localized to the DRG (Fig. 5E),
consistent with previous studies indicating that the majorityFig. 5. Ectopic NELL2 expression autocrinely biases transfected neural
crest cells to localize in the DRG. (A) GFP control transfected neural
crest cells have migrated to their appropriate destinations by stage 18–
20/E3 in both the prospective DRG, D, and sympathetic ganglia, S, and
continue to contribute to the primary chain of sympathetic ganglia at
stage 25/E4.5; ao, aorta; sc, spinal cord. In contrast, ectopic NELL2 (B)
expression biased migrating neural crest cells to preferentially localize to
the DRG anlagen, D, at stage 18–20/E3 rather than the sympathetic
ganglia, S, ao, aorta; sc, spinal cord. (C) Control-GFP-transfected cells
contribute to the sympathetic ganglia, identified with the neural marker
Ben (red). (D) In contrast, NELL2-transfected cells are absent from
sympathetic ganglia. (E) Quantification of the location of transfected
cells at stage 18–20/E3. GFP:1117 cells; n = 3 embryos; Nell2: 246
cells, n = 3 embryos; P V 0.007. Scale bar: A, B, 30 Am; C, D, 10 Am.of neural crest cells contribute to the DRG because of their
larger size at this stage (Perez et al., 1999). This functional
bias is consistent with our expression analysis that demon-
strated that while NELL2 was strongly expressed by a
subset of migrating neural crest and in the DRG anlagen,
it was not similarly expressed in the primary nor secondary
chain of sympathetic ganglia (Nelson et al., 2002).
ental Biology 270 (2004) 322–335NELL2 promotes the differentiation of neural crest cells into
sensory neurons
To investigate the fate of NELL2-transfected neural crest
cells localized in the DRG, we determined their identity with
an array of neuronal markers: Ben, Hu, Tuj1, Isl1, TrkA,
TrkB, TrkC. At stage 18–20 (early E3), gangliogenesis has
begun and the first neurons have differentiated (Lallier and
Bronner-Fraser, 1988; Pannese, 1974; Teillet et al., 1987).
However, the majority of cells in the nascent ganglia are
progenitor cells that do not express neural markers; rather,
they encapsulate the newly differentiating cluster of neurons
that aggregate in the inner core of the ganglion (Fig. 6A).
Ectopic NELL2 expression resulted in a clear bias, in which
NELL2+ cells were significantly more likely to be neurons
than were control GFP-transfected cells (Fig. 6I). Even
during the earliest stages of ganglion formation when neural
markers are first expressed, 64.0 F 4.7% of NELL2-trans-
B.R. Nelson et al. / Developm330Fig. 6. Ectopic NELL2 expression autocrinely promotes the differentiation of tran
embryo at stage 18–20/E3, immunolabeled with a neuronal marker (Tuj1, red),
(asterisk) encapsulated by transfected progenitor cells (arrows); note transfected
transfected neural crest cells localized to the DRG anlagen express neuronal mark
red). (C, D) At E4.5, the peak period of sensory neurogenesis and differentiation
(Ben, red) are in the core of the ganglion (asterisk); non-neuronal transfected cells
layer (arrowheads), in the ventral motor root (arrow). (D) In contrast, the majority
red), and not detected in progenitor zones. (E–H) Ectopic NELL2 does not alter se
cells are TrkC+. (F) E6.5 control GFP-transfected TrkB+ neurons (arrows), TrkB-n
transfected TrkA+ neurons (G, arrow), TrkB+ neurons (H, arrows). (I) Quantificat
compiled and compared for control and NELL2-transfected embryos: GFP, stage
embryos; P V 0.001. GFP, stage 25/E4.5: 659 cells, n = 3 embryos; NELL2, stage
12 Am; C, 20 Am; E–H, 50 Am.fected cells (Figs. 6B, I) already expressed neural markers
compared to 15.0% + 0.4% (P V 0.001) of control GFP-
transfected cells (Figs. 6A, I). This is a conservative
estimate, as NELL2-transfected cells with clear neuronal
morphology not expressing these later neural markers were
often observed (Fig. 6B). Furthermore, while axons from
transfected NELL2 neurons were detected in peripheral
nerve tracts, NELL2-transfected cells (i.e., Schwann cells)
were not observed (not shown). During the peak period of
sensory neurogenesis and differentiation in control embryos
(stage 25/E4.5), GFP expression was detected in nascent
neurons and non-neural cells in the core of the ganglion, in
progenitor cells in the dorsal pole and in the perimeter, and
in non-neural cells in the dorsal root and in the ventral motor
tracts (Figs. 6C, I). In contrast, the vast majority of NELL2-
transfected cells expressed neuronal markers (87.0 F 4.3%,
P V 0.003) and were confined to the neural core of the
ganglion (Figs. 6D, E, I).sfected neural crest cells into sensory neurons. (A) Control GFP-transfected
demonstrates that in the DRG anlagen, transfected neurons are in the core
cells in the ventral root (arrowhead). (B) By E3, the majority of NELL2-
ers (Ben, red; arrow) or appear neuronal by morphology (arrowhead; Ben,
, control GFP-transfected cells (C) immunolabeled with neuronal markers
are detected in the progenitor zones in the dorsal pole and ensheathing cell
of NELL2-transfected cells are immunolabeled with neuronal markers (Ben,
nsory subtype identity. (E) At E4.5, the vast majority of NELL2-transfected
eurons (arrowheads), and non-neuronal cells (asterisk). (G, H) E6.5 NELL2-
ion of positive expression of the neuronal markers Ben, tuj-1, and trkC was
18–20: 439 cells, n = 3 embryos; NELL2, stage 18–20: 224 cells, n = 6
25/E4.5: 357 cells, n = 5 embryos, P V 0.003. Scale bar: A, D, 40 Am; B,
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fected cells in the DRG, we analyzed whether ectopic-
NELL2 expression influenced the production of neuronal
subtypes, which can be loosely categorized as TrkA (noci-
ceptors), TrkB (mechanoreceptors), or TrkC (proprioceptors)
neurons (Lefcort et al., 1996; Oakley et al., 1997, 2000). At
E4.5, TrkC is expressed by all of the nascent neurons and a
subset of progenitors resident in the core of the ganglion
(Rifkin et al., 2000). Accordingly at this stage, the vast
majority of NELL2-transfected cells were TrkC+ and
appeared neuronal (Fig. 6E). At E6.5, ectopic NELL2
expressing cells appeared neuronal and could express any
of the three Trk receptors (TrkA 7/30 cells, Fig. 6G; TrkB 53/
54 cells, Fig. 6H; TrkC 11/22 cells). Ectopic control GFP-
transfected cells at E6.5 included TrkB (+) and () neuronsFig. 7. Neuron-secreted NELL2 paracrinely induces mitogenesis within the nascen
(red) reveals that the majority of transfected cells are not adjacent to mitotically acti
cells with a definite neuronal morphology are frequently observed tightly juxtapose
embryos of the same stage, nascent neurons (Tuj1+, red) are seldom in contact w
arrowheads denote noncontact). (D) Quantification of contacts between NELL2-tr
cells, n = 4 embryos; NELL2: 127 cells, n = 3 embryos; P V 0.0001. (E) Quantif
cells that are in both the GFP and NELL2-transfected DRG, rather than in the DRG
H3+ cells in both experimental side and contralateral control side DRG). GFP: 459
bar: 20 Am.and glial cells (TrkB 48/100 cells, Fig. 6F; TrkA 30/92 cells,
TrkC 3/15 cells). These results suggest that NELL2 may
promote the differentiation of TrkB sensory neurons over
other Trk subtypes. However, this apparent bias could be
because TrkB neurons normally differentiate during the first
(Ngn2-dependent) wave of neurogenesis, and since ectopic-
NELL2 expression in transfected progenitors would have
driven progenitors out of the cell cycle, the pool of GFP+
progenitor cells remaining to give rise to the second (Ngn-1
dependent) wave of neurogenesis (in which the majority of
trkA+ cells are generated) could have been significantly
depleted. Interestingly, maximal NELL2 expression does
correlate temporally with the first wave of neurogenesis in
the DRG, decreasing after approximately E6 as the second
Ngn1-dependent wave of neurogenesis begins (Nelson et al.,t DRG. (A) At E3, control GFP-transfected embryo immunolabeled with H3
ve progenitor cells (arrowheads). (B) In contrast, ectopic NELL2-transfected
d to mitotically active progenitor cells (arrowheads). (C) In nonexperimental
ith mitotically active progenitor cells (H3+, green; arrow denotes contact,
ansfected nascent neurons and mitotically active progenitor cells. GFP: 325
ication of mitogenic effect of ectopic NELL2. The mean percentage of H3+
on the contralateral nontransfected side, is shown (100% = total number of
cells, n = 4 embryos; NELL2: 131 cells, n = 2 embryos; P V 0.028. Scale
B.R. Nelson et al. / Developmental Biology 270 (2004) 322–3353322002). Although the majority of TrkA+ cells are generated
during this second wave of neurogenesis, a few TrkA+/
NELL2+ transfected neurons were observed (Fig. 6G).
Whether these TrkA+/NELL2+ cells were generated from
later Ngn1 progenitors is not known, as some TrkA sensory
neurons are also generated during the first wave of neuro-
genesis (Ma et al., 1999; Rifkin et al., 2000). Targeted
transfection of progenitors during the second wave of neuro-
genesis will be required to conclusively determine the effect
of NELL2 on sensory neural subtype. Therefore, at this
point, we conclude that NELL2 promotes the differentiation
of a sensory neuronal fate rather than a glial fate without
apparently influencing the specificity of sensory neuronal
subtype.
Neuron-secreted NELL2 induces mitogenesis of adjacent
cells within the nascent DRG
Since NELL2 is secreted from transfected cells in ovo, we
investigated whether secreted NELL2 influenced the fate of
adjacent cells. In our in situ hybridization analysis, we
noticed that NELL2+ postmitotic cells were often directly
juxtaposed to mitotically active progenitor cells in the CNS
and PNS (Nelson et al., 2002). To determine whether NELL2
had mitogenic activity on adjacent cells in the nascent DRG
in ovo, we immunolabeled sections of transfected embryos
with anti-phophoH3, a marker of cells in M phase. In control
GFP-transfected embryos, 18.3 F 1.3% of the transfected
cells were in contact with H3 immunopositive cells (Figs. 7A,
D). In contrast, 56.0 F 4.0% (P V 0.0001) of NELL2-
transfected cells were found juxtaposed to H3+ cells
(Figs. 7B, D). To determine whether this was an indirect
effect of the increased neuronal differentiation of NELL2-
transfected cells, we determined the normal percentage of
neurons in nontransfected embryos that were adjacent to
H3+ progenitor cells in the nascent DRG. We found that in
normal, nonexperimental animals, 27.1 F 2.3% of nascent
neurons were in contact with H3+ progenitors (Fig. 7C). This
apparent induction of mitogenesis by NELL2-transfected
neurons consequently resulted in an increase in the total
number of H3+ cells observed in NELL2-transfected DRG
(62.5 F 2.5%) compared to contralateral nontransfected
DRG, and to control GFP-transfected and contralateral non-
transfected DRG (48.3 F 0.0%, P V 0.028; Fig. 7E). Thus,
neuron-secreted NELL2 can apparently paracrinely stimulate
the mitogenesis of cells within the immature DRG in ovo.Discussion
These data demonstrate that during the development of
the nervous system, NELL2 can alter the behavior of both
CNS and PNS progenitor cells. We report here that chicken
NELL2 is secreted from in ovo transfected spinal cords and
forms a homotrimer in solution. Ectopic expression of
NELL2 induces the precocious differentiation of CNSprogenitor cells and biases migrating neural crest cells to
preferentially localize to the DRG anlagen, promoting their
differentiation into sensory neurons in a cell autonomous
manner. Furthermore, within the nascent DRG, neuron-
secreted NELL2 paracrinely stimulates adjacent cells to
proliferate.
These are the first reported in vivo functions for NELL2
and are striking in that molecules typically identified as
mediating neuronal differentiation have been members of
the achaete-scute and atonal proneural transcription factor
families, that is, Mash, neurogenins, NeuroD (reviewed by
Lee, 1997). Misexpression experiments with proneural
transcription factors in the CNS have demonstrated their
ability to promote neuronal differentiation (Cai et al., 2000;
Lamar et al., 2001; Lee, 1997). Some bHLH transcription
factors can couple neuronal differentiation with specifica-
tion of neuronal identity, that is, Mash and Ngn1, resulting
in the expansion of particular classes of neurons at the
expense of others (Cai et al., 2000; Lo et al., 2002; Parras
et al., 2002). In contrast, ectopic NELL2 expression does
not specify neuronal subtype within the spinal cord but
rather drives CNS progenitor cells out of the cell cycle
promoting their differentiation. In this regard, it is interest-
ing that the expression pattern of NELL2 in the spinal cord
overlaps with that of NeuroM and NKL, bHLH and zinc-
finger transcription factors, respectively (Lamar et al., 2001;
Roztocil et al., 1997). Expression of all three genes
becomes restricted within the spinal cord by E4.5 to nascent
postmitotic neurons (Lamar et al., 2001; Nelson et al., 2002;
Roztocil et al., 1997). Ectopic expression of NELL2 or
NKL in CNS progenitor cells is sufficient to drive them out
of the cell cycle forcing progenitors to emigrate from the
ventricular zone and differentiate into neurons (Figs. 2 and
3; Lamar et al., 2001). Based on their restricted expression
patterns and activities in the spinal cord, it is likely that
NELL2, NeuroM, and NKL act in combination with, or
downstream from, other bHLH transcription factors and
lateral inhibitory systems to activate or maintain the differ-
entiation state of postmitotic neurons in a cell autonomous
manner (Lamar et al., 2001).
In the PNS, we have shown that NELL2 is expressed by
a subset of migrating neural crest cells, and maximally
expressed in the DRG anlagen through the peak period of
sensory neurogenesis and differentiation, while not being
similarly expressed in the primary nor secondary chain of
sympathetic ganglia (Nelson et al., 2002). This early ex-
pression pattern of NELL2 in a subset of migrating neural
crest cells parallels the transient expression of Ngn2, which
is restricted to the earliest progenitor cells in the DRG
anlagen that generate the first wave of TrkB and TrkC
sensory neuronal subtypes (Ma et al., 1999; Perez et al.,
1999). Ngn1 expression ensues as the DRG matures, re-
stricted to progenitor domains in the immature ganglion—
presumably in a separate set of sensory progenitor cells
responsible for generating the second wave of later arising
TrkA sensory neuronal subtypes (Ma et al., 1999). Within
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neurons and a subset of mitotically active progenitor cells
(Nelson et al., 2002). The number of these mitotically active
(BrdU+) NELL2+ progenitor cells decreases over time,
tightly correlated with the differentiation of neuronal pro-
genitor cells (Nelson et al., 2004). The vast majority of
NELL2 expressing cells are nascent, postmitotic neurons,
often in direct contact with non-NELL2 expressing progen-
itors cells, reminiscent of the classical lateral inhibition
interaction mediated by Notch and Delta (Morrison et al.,
2000; Wakamatsu et al., 2000). Finally, NELL2 expression
wanes as nascent neurons mature, being restricted tempo-
rally to the peak period of neuronal differentiation within the
DRG (Nelson et al., 2002).
The precise role of the Ngns in the development of the
peripheral sensory nervous system remains complex as
recent fate-mapping studies demonstrate that the Ngn2+
sensory-specific neural crest cell subpopulation gives rise
to both neurons and glia equally, with no apparent bias in
sensory neural subtypes, and that Ngn2 expressing progen-
itors can migrate to the sympathetic ganglia (Zirlinger et al.,
2002). Previous studies have demonstrated that ectopic
expression of Ngn2 and Ngn1 biased migrating neural crest
cells to localize in the DRG anlagen, and to differentiate into
sensory neurons (Perez et al., 1999). We show here that
ectopic expression of NELL2 in premigratory neural crest
cells also biased them to preferentially localize to the
nascent DRG, and to differentiate into sensory neurons
rather than glia without apparently altering sensory subtype,
in a cell autonomous manner. NELL2 overexpression in
migrating neural crest cells could drive them to localize in
the DRG anlagen by causing their premature withdrawal
from the cell cycle and by default, their differentiation into
(DRG) neurons thereby precluding further ventral migra-
tion. Alternatively, NELL2 may instruct migrating neural
crest cells to specifically localize to the DRG and differen-
tiate into sensory neurons since NELL2 is normally prefer-
entially expressed by this lineage of the neural crest (Nelson
et al., 2002).
Electron microscopy in the adult rat brain has demon-
strated NELL2 association with the rough ER, and that
NELL2 was exclusively expressed by neurons and not
detected in any glial derivatives, which further support that
NELL2 is secreted by neurons in vivo (Oyasu et al., 2000).
We have demonstrated that, in vivo, neuron-secreted
NELL2 paracrinely stimulates mitogenesis of adjacent cells
in the nascent DRG, inhibiting them from differentiating,
reminiscent of the juxtacrine signaling activity of Delta to
adjacent Notch-expressing progenitor cells. NELL2 expres-
sion normally decreases in sensory neurons as they mature,
thereby potentially removing a mitogenic stimulus and
facilitating the differentiation of later-born neurons and/or
glia. Interestingly, NELL2 and NELL1 have been detected
in several transformed cell lines, hyperplasias, and malig-
nancies, indicating that misregulation of NELL genes is
correlated with oncogenic potential in certain cancerouspathologies (DiLella et al., 2001; Kuroda et al., 1999; Luce
and Burrows, 1999; Maeda et al., 2001).
How NELL2, a secreted glycoprotein, could simulta-
neously exert both cell autonomous and paracrine activities
is not yet understood. NELL2 could induce an intracellular
signal during its biosynthesis in the secretory pathway, or
activate cells extracellularly via an autocrine cell–surface
interaction as has been shown for BDNF in adult sensory
neurons (Acheson et al., 1995). Cell–surface interactions
between Notch and Delta are known to occur within
progenitor cells before committing to Notch-only or Delta-
only expression (reviewed by Gaiano and Fishell, 2002).
The similarities between the classical lateral inhibition
pathway and the cell autonomous and paracrine functions
of NELL2 raise the intriguing possibility that NELL2 may
directly or indirectly interact with the Notch pathway, a
hypothesis currently being tested. Recently, it has been
suggested that NELL2 could regulate synaptic vesicle
transport or release through a Ca+2-mediated signaling
pathway (Kim et al., 2002). Additionally, NELL2 can
promote the survival of embryonic rat cortical neurons in
culture via a MAP kinase signaling pathway (Aihara et al.,
2003). Finally, NELL2 either directly or indirectly could
interact with Wnt/h-catenin signaling pathway, which has
been shown to be required for sensory neuron differentiation
within the DRG (Hari et al., 2002). Secreted NELL2 also
binds to heparin sulfate in vitro (Kuroda et al., 1999)
suggesting another possible mechanism of direct interaction
of NELL2 with cell surface receptors such as heparin sulfate
proteoglycans or FGF receptor–heparin complexes, or in-
directly with the heparin sulfate-rich extracellular matrix
(HS-ECM). Finally, NELL2 could also bind other secreted
factors since it contains cysteine-rich chordin-like/von Wil-
lebrand factor-C and N-TSP1 motifs, which can interact
with TGFh/BMP family members and a myriad of cell–
surface and ECM molecules, respectively (reviewed in
Adams and Tucker, 2000; Bornstein and Sage, 2002; Garcia
Abreu et al., 2002).
In summary, we have demonstrated that NELL2 has dual
cell autonomous and paracrine functions, promoting differ-
entiation of neuronal progenitor cells that express NELL2
while simultaneously stimulating neighboring cells in the
DRG to proliferate. It would seem then as if NELL2
activates and/or maintains a neuronal differentiation pro-
gram within spinal cord and sensory neuron precursors
without influencing neuronal subtype decisions. Interesting-
ly, mouse embryonic stem cells upregulate NELL2 expres-
sion when induced to differentiate into neurons in response
to retinoic acid (Guo et al., 2001). As NELL2 expression
wanes in maturing neurons, a loss of its mitogenic stimulus
would allow remaining progenitors to differentiate into
later-born neurons and/or glia. Recently, it was demonstrat-
ed that overexpression of NELL1 in transgenic mice
resulted in premature osteoblast differentiation (Zhang
et al., 2002), consistent with its misexpression in coronal
synostosis (Ting et al., 1999). Although these studies did not
B.R. Nelson et al. / Developmental Biology 270 (2004) 322–335334address paracrine functions of secreted NELL1, the cell
autonomous effects of NELL1 overexpression and the
resulting premature differentiation of osteoblasts suggest
that the NELL gene family promotes the differentiation of
cells in which they are expressed. A similarly complex role
for another secreted glycoprotein Noelin-1 demonstrates
that secreted glycoproteins can regulate the behavior of
neural progenitors (Barembaum et al., 2000; Morenoi and
Bronner-Fraser, 2001). The elucidation of the mechanisms
by which a single protein can exert dual cell autonomous
and paracrine functions is of great interest and the focus of
ongoing studies.Acknowledgments
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